Toll-like receptor 4: A potential therapeutic target for multiple human diseases

被引：19
|
作者：
Wei, Jinrui [1 ,2 ,3 ]
Zhang, Yan [1 ,2 ,3 ]
Li, Haopeng [1 ,2 ,3 ]
Wang, Fuquan [1 ,2 ,3 ]
Yao, Shanglong [1 ,2 ,3 ,4 ]
机构：
[1] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Anesthesiol, Wuhan 430022, Peoples R China
[2] Huazhong Univ Sci & Technol, Union Hosp, Inst Anesthesia & Crit Care Med, Tongji Med Coll, Wuhan 430022, Peoples R China
[3] Huazhong Univ Sci & Technol, Key Lab Anesthesiol & Resuscitat, Minist Educ, Hongshan, Peoples R China
[4] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Anesthesiol, 1277 Jiefang Ave, Wuhan 430022, Peoples R China
来源：
BIOMEDICINE & PHARMACOTHERAPY | 2023年 / 166卷
关键词：
Immune response; Toll -like receptor 4; Cardiovascular; Neoplastic; Inflammatory; NF-KAPPA-B; ESOPHAGEAL CANCER-CELLS; TRAUMATIC BRAIN-INJURY; NLRP3; INFLAMMASOME; REGULATORY FACTOR-3; ADHESION MOLECULES; SIGNALING PATHWAYS; ACTIVATION; TLR4; LIPOPOLYSACCHARIDE;
D O I：
10.1016/j.biopha.2023.115338
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
The immune response plays a pivotal role in the pathogenesis of diseases. Toll-like receptor 4 (TLR4), as an intrinsic immune receptor, exhibits widespread in vivo expression and its dysregulation significantly contributes to the onset of various diseases, encompassing cardiovascular disorders, neoplastic conditions, and inflammatory ailments. This comprehensive review centers on elucidating the architectural and distributive characteristics of TLR4, its conventional signaling pathways, and its mode of action in diverse disease contexts. Ultimately, this review aims to propose novel avenues and therapeutic targets for clinical intervention.
引用
收藏
页数：9
相关论文
共 50 条
  • [21] Toll-like receptor signalling as a cannabinoid target in multiple sclerosis
    Fitzpatrick, John-Mark
    Kjuiper, Teun
    Hogan, Tracy
    O'Toole, Orna
    Hind, William
    Downer, Eric J.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 : S293 - S293
  • [22] Adaptors in Toll-Like Receptor Signaling and their Potential as Therapeutic Targets
    Ve, Thomas
    Gay, Nicholas J.
    Mansell, Ashley
    Kobe, Bostjan
    Kellie, Stuart
    CURRENT DRUG TARGETS, 2012, 13 (11) : 1360 - 1374
  • [23] The role of toll-like receptor 4 (TLR4) in cancer progression: A possible therapeutic target?
    Kashani, Bahareh
    Zandi, Zahra
    Pourbagheri-Sigaroodi, Atieh
    Bashash, Davood
    Ghaffari, Seyed H.
    JOURNAL OF CELLULAR PHYSIOLOGY, 2021, 236 (06) : 4121 - 4137
  • [24] Toll-like receptors as a potential therapeutic target for atherosclerosis and cardiovascular disease
    Lacheta, Dominika
    Olejarz, Wioletta
    Wrzosek, Malgorzata
    Nowicka, Grazyna
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2018, 72 : 728 - 739
  • [25] Impaired responses to toll-like receptor 4 and toll-like receptor 3 ligands in human cord blood
    De Wit, D
    Tonon, S
    Olislagers, V
    Goriely, S
    Boutriaux, M
    Goldman, M
    Willems, F
    JOURNAL OF AUTOIMMUNITY, 2003, 21 (03) : 277 - 281
  • [26] Identification of toll-like receptor 3 as a potential therapeutic target in clear cell renal cell carcinoma
    Morikawa, Teppei
    Sugiyama, Akira
    Kume, Haruki
    Ota, Satoshi
    Kashima, Takeshi
    Tomita, Kyoichi
    Kitamura, Tadaichi
    Kodama, Tatsuhiko
    Fukayama, Masashi
    Aburatani, Hiroyuki
    CLINICAL CANCER RESEARCH, 2007, 13 (19) : 5703 - 5709
  • [27] Toll-Like Receptor 3 as a Recurrence Risk Factor and a Potential Molecular Therapeutic Target in Colorectal Cancer
    Yoshida, Tatsuya
    Miura, Takuya
    Matsumiya, Tomoh
    Yoshida, Hidemi
    Morohashi, Hajime
    Sakannoto, Yoshiyuki
    Kurose, Akira
    Imaizumi, Tadaatsu
    Hakannada, Kenichi
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2020, 13 : 427 - 438
  • [28] The Therapeutic Potential of Targeting the Toll-like Receptor Pathway in Breast Cancer
    Toroghian, Younes
    Khayyami, Reza
    Hassanian, Seyed Mahdi
    Nassiri, Mohammadreza
    Ferns, Gordon A.
    Khazaei, Majid
    Avan, Amir
    CURRENT PHARMACEUTICAL DESIGN, 2022, 28 (27) : 2203 - 2210
  • [29] The potential of targeting Toll-like receptor 2 in autoimmune and inflammatory diseases
    E. M. Pålsson-McDermott
    L. A. J. O’Neill
    Irish Journal of Medical Science, 2007, 176 : 253 - 260
  • [30] The potential of targeting Toll-like receptor 2 in autoimmune and inflammatory diseases
    Palsson-McDermott, E. M.
    O'Neill, L. A. J.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2007, 176 (04) : 253 - 260
12345